NEUTROGENA RAPID CLEAR FOAMING SCRUB- salicylic acid gel 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

NEUTROGENA Rapid Clear ® Foaming Scrub

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne treatment

Use

For the treatment of acne.

Warnings

For external use only.

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with eyes. If contact occurs, flush thoroughly with water.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Cleanse twice a day. Wet face. Apply to hands, add water and work into a lather.
  • Massage gently.
  • Rinse thoroughly.

Other Information

Store at Room Temperature.

Inactive ingredients

Water, Sodium C14-16 Olefin Sulfonate, Glycerin, Cocamidopropyl Betaine, Microcrystalline Cellulose, Acrylates Copolymer, Fragrance, Polysorbate 20, Sodium Hydroxide, C12-15 Alkyl Lactate, Benzalkonium Chloride, Polyquaternium-7, Disodium EDTA, Menthol, Cocamidopropyl PG-Dimonium Chloride Phosphate, Sodium Benzotriazolyl Butylphenol Sulfonate, Carrageenan, Agar, Ascorbyl Palmitate, Iron Oxides, Yellow 5, Red 40, Mica, Red 30, Titanium Dioxide

Questions?

Call toll-free 800-582-4048 or 215-273-8755 (collect) or visit www.neutrogena.com

Distributed by:
JOHNSON & JOHNSON CONSUMER INC.
Skillman, NJ 08558

PRINCIPAL DISPLAY PANEL - 125 mL Tube Label

NEW &
IMPROVED
NEUTROGENA
Rapid
Clear ®
Foaming Scrub

MICRO CLEAR®
technology

visibly reduces
breakouts

Neutrogena ®

salicylic acid acne treatment
4.2 FL OZ (125mL)

PRINCIPAL DISPLAY PANEL - 125 mL Tube Label
NEUTROGENA RAPID CLEAR FOAMING SCRUB 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69968-0128
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
GLYCERIN (UNII: PDC6A3C0OX)  
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
BUTYL ACRYLATE/METHYL METHACRYLATE/METHACRYLIC ACID COPOLYMER (18000 MW) (UNII: JZ1374NL9E)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
C12-15 ALKYL LACTATE (UNII: GC844VRD7E)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) (UNII: 0L414VCS5Y)  
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)  
COCAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: H2KVQ74JM4)  
SODIUM BENZOTRIAZOLYL BUTYLPHENOL SULFONATE (UNII: 0LA2QC9O3Z)  
CARRAGEENAN (UNII: 5C69YCD2YJ)  
AGAR, UNSPECIFIED (UNII: 89T13OHQ2B)  
ASCORBYL PALMITATE (UNII: QN83US2B0N)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 30 (UNII: 2S42T2808B)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69968-0128-4125 mL in 1 TUBE; Type 0: Not a Combination Product10/01/201608/01/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D10/01/201608/01/2022
Labeler - Johnson & Johnson Consumer Inc. (002347102)

Revised: 6/2021
Document Id: c4281e32-24ac-f63a-e053-2995a90ab787
Set id: 85ef4560-bebf-4afe-b8f6-6e9ba8a2a153
Version: 4
Effective Time: 20210607
 
Johnson & Johnson Consumer Inc.